Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Larynx cancer survival model developed through open-source federated learning.
Rønn Hansen C, Price G, Field M, Sarup N, Zukauskaite R, Johansen J, Eriksen JG, Aly F, McPartlin A, Holloway L, Thwaites D, Brink C. Rønn Hansen C, et al. Among authors: mcpartlin a. Radiother Oncol. 2022 Nov;176:179-186. doi: 10.1016/j.radonc.2022.09.023. Epub 2022 Oct 5. Radiother Oncol. 2022. PMID: 36208652 Free article.
Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life.
Sanmamed N, Lee J, Berlin A, Craig T, Lao B, Rink A, Bayley A, Catton C, Sundaramurthy A, Foltz W, McPartlin A, Ghai S, Astenafu E, Gospodarowicz M, Warde P, Ménard C, Chung P. Sanmamed N, et al. Among authors: mcpartlin a. Radiother Oncol. 2020 Aug;149:240-245. doi: 10.1016/j.radonc.2020.05.029. Epub 2020 May 22. Radiother Oncol. 2020. PMID: 32447033
Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
Price JM, West CM, Dixon LM, Iyizoba-Ebozue Z, Garcez K, Lee LW, McPartlin A, Slevin F, Sykes A, Prestwich RJD, Thomson DJ. Price JM, et al. Among authors: mcpartlin a. Radiother Oncol. 2022 Jul;172:111-117. doi: 10.1016/j.radonc.2022.05.013. Epub 2022 May 17. Radiother Oncol. 2022. PMID: 35595173
Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117].
Price JM, West CM, Dixon LM, Iyizoba-Ebozue Z, Garcez K, Lee LW, McPartlin A, Williams G, Slevin F, Sykes A, Prestwich RJD, Thomson DJ. Price JM, et al. Among authors: mcpartlin a. Radiother Oncol. 2022 Dec;177:163. doi: 10.1016/j.radonc.2022.10.014. Epub 2022 Nov 14. Radiother Oncol. 2022. PMID: 36395551 No abstract available.
First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer.
Dubec MJ, Buckley DL, Berks M, Clough A, Gaffney J, Datta A, McHugh DJ, Porta N, Little RA, Cheung S, Hague C, Eccles CL, Hoskin PJ, Bristow RG, Matthews JC, van Herk M, Choudhury A, Parker GJM, McPartlin A, O'Connor JPB. Dubec MJ, et al. Among authors: mcpartlin a. Radiother Oncol. 2023 Jun;183:109592. doi: 10.1016/j.radonc.2023.109592. Epub 2023 Mar 3. Radiother Oncol. 2023. PMID: 36870608 Free article.
55 results